diabetestalk.net

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy

Global Prevalence and Major Risk Factors of Diabetic Retinopathy 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia 2Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore 6Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands 12National Cancer Center/Department of Neurosurgery, Advanced Molecular Epidemiology Research Institute, Faculty of Medicine, Yamagata University, Yamagata, Japan 31Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia 2Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore 32Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 1Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia 2Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore 3Global Health Outcomes Strategy and Research, Allergan Inc., Irvine, California 4Departm Continue reading >>

Diabetic Retinopathy And The Associated Risk Factors In Diabetes Type 2 Patients In Abha, Saudi Arabia Ahmed Ra, Khalil Sn, Al-qahtani Ma - J Fam Community Med

Diabetic Retinopathy And The Associated Risk Factors In Diabetes Type 2 Patients In Abha, Saudi Arabia Ahmed Ra, Khalil Sn, Al-qahtani Ma - J Fam Community Med

Diabetes mellitus (DM) has been known as a potentially disabling chronic disease with multiple complications. [1] In the Kingdom of Saudi Arabia (KSA), diabetes has emerged as a major public health problem that has reached an epidemic stage. [2] The crude prevalence of diabetes has been documented as 23.7%, accounting for 37.8% of Saudis aged between 30 and 70 years. [3] With the advances in the healthcare facilities in the Kingdom, the life expectancy of diabetic patients has increased. Therefore, the complications associated with longer duration of the disease have become one of the challenges faced by health care institutions. Of these complications, a retinal vascular disorder, retinopathy is considered the leading cause of blindness in the working age population [4] and accounts for considerable adult work disability. [5] Its presence may also indicate and predict other diabetic complications. [6] It is documented that more than 77% of patients who survive for over 20 years with DM are affected by retinopathy. [7] Untreated diabetic retinopathy (DR) not only leads to blindness, which is a personal catastrophe for the individual but also increases the economic burden of health care servicesin the community. [8] DR is characterized by signs of retinal ischemia (retinal microvascular abnormalities, microaneurysms, hemorrhages, intra-venous caliber abnormalities, cotton-wool spots, and neovascularization) and/or signs of increased retinal vascular permeability. Vision loss can result from several mechanisms, including neovascularization leading to vitreous hemorrhage and/or retinal detachment, macular edema, and retinal capillary nonperfusion. [4] Depending on these signs, retinopathy is classified into nonproliferative diabetic retinopathy (NPDR) and proliferative re Continue reading >>

Welcome To Cdc Stacks | Global Prevalence And Major Risk Factors Of Diabetic Retinopathy - 12430 | Cdc Public Access

Welcome To Cdc Stacks | Global Prevalence And Major Risk Factors Of Diabetic Retinopathy - 12430 | Cdc Public Access

To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 2079 years. A total of 35 studies (19802008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.534.8) for any DR, 6.96% (6.877.04) for proliferative DR, 6.81% (6.746.89) for diabetic macular edema, and 10.2% (10.110.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A1c, and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics. Mendoza-Herrera, Kenny; Quezada, Amado D.; Pedroza-Tobas, Andrea; Hernndez-Alcaraz, Cesar; Continue reading >>

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy

Global prevalence and major risk factors of diabetic retinopathy Research output: Contribution to journal Journal article Global prevalence and major risk factors of diabetic retinopathy. / Yau, Joanne W Y; Rogers, Sophie L; Kawasaki, Ryo; Lamoureux, Ecosse L; Kowalski, Jonathan W; Bek, Toke; Chen, Shih-Jen; Dekker, Jacqueline M; Fletcher, Astrid ; Grauslund, Jakob ; Haffner, Steven; Hamman, Richard F; Ikram, M Kamran; Kayama, Takamasa; Klein, Barbara E K; Klein, Ronald; Krishnaiah, Sannapaneni; Mayurasakorn, Korapat; O'Hare, Joseph P; Orchard, Trevor J; Porta, Massimo; Rema, Mohan; Roy, Monique S; Sharma, Tarun; Shaw, Jonathan; Taylor, Hugh; Tielsch, James M; Varma, Rohit; Wang, Jie Jin; Wang, Ningli; West, Sheila; Xu, Liang; Yasuda, Miho; Zhang, Xinzhi; Mitchell, Paul; Wong, Tien Y; Meta-Analysis for Eye Disease (META-EYE) Study Group. In: Diabetes Care , Vol. 35, No. 3, 2012, p. 556-64. Research output: Contribution to journal Journal article Yau, JWY, Rogers, SL, Kawasaki, R, Lamoureux, EL, Kowalski, JW, Bek, T, Chen, S-J, Dekker, JM, Fletcher, A , Grauslund, J , Haffner, S, Hamman, RF, Ikram, MK, Kayama, T, Klein, BEK, Klein, R, Krishnaiah, S, Mayurasakorn, K, O'Hare, JP, Orchard, TJ, Porta, M, Rema, M, Roy, MS, Sharma, T, Shaw, J, Taylor, H, Tielsch, JM, Varma, R, Wang, JJ, Wang, N, West, S, Xu, L, Yasuda, M, Zhang, X, Mitchell, P, Wong, TY & Meta-Analysis for Eye Disease (META-EYE) Study Group 2012, ' Global prevalence and major risk factors of diabetic retinopathy ' Diabetes Care , vol 35, no. 3, pp. 556-64. DOI: 10.2337/dc11-1909 Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., ... Meta-Analysis for Eye Disease (META-EYE) Study Group (2012). Global prevalence and major risk factors of diabetic retinopathy . Diabetes Care Continue reading >>

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy.

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy.

Diabetes Care. 2012 Mar;35(3):556-64. doi: 10.2337/dc11-1909. Epub 2012 Feb 1. Global prevalence and major risk factors of diabetic retinopathy. Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia. To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20-79 years. A total of 35 studies (1980-2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5-34.8) for any DR, 6.96% (6.87-7.04) for proliferative DR, 6.81% (6.74-6.89) for diabetic macular edema, and 10.2% (10.1-10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A(1c), and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the i Continue reading >>

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy On Behalf Of The Meta-analysis For Eye Disease (meta-eye) Study Group* | Miguel Angel Vazquez Membrillo - Academia.edu

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy On Behalf Of The Meta-analysis For Eye Disease (meta-eye) Study Group* | Miguel Angel Vazquez Membrillo - Academia.edu

Global Prevalence and Major Risk Factors of Diabetic Retinopathy ON BEHALF OF THE META-ANALYSIS FOR EYE DISEASE (META-EYE) STUDY GROUP* Global Prevalence and Major Risk Factors of Diabetic Retinopathy ON BEHALF OF THE META-ANALYSIS FOR EYE DISEASE (META-EYE) STUDY GROUP* Epidemiology/Health Services Research O R I G I N A L A R T I C L EGlobal Prevalence and Major RiskFactors of Diabetic Retinopathy DJOANNE W.Y. YAU, MBBS1 TREVOR J. ORCHARD, MD17 iabetic retinopathy (DR) is the lead-SOPHIE L. ROGERS, MEPID1 MASSIMO PORTA, PHD18 ing cause of blindness among working-RYO KAWASAKI, PHD1 MOHAN REMA, MD19 aged adults around the world (1).ECOSSE L. LAMOUREUX, PHD1,2 MONIQUE S. ROY, MD20 Despite the signicance of this problem,JONATHAN W. KOWALSKI, PHARMD3 TARUN SHARMA, MD21TOKE BEK, PHD4 JONATHAN SHAW, PHD22 and the rising prevalence of diabetes no-SHIH-JEN CHEN, PHD5 HUGH TAYLOR, AC23 tably in emerging Asian countries suchJACQUELINE M. DEKKER, PHD6 JAMES M. TIELSCH, PHD24 as India and China (2,3), there are fewASTRID FLETCHER, PHD7 ROHIT VARMA, MD25 precise contemporary estimates of theJAKOB GRAUSLUND, MD8 JIE JIN WANG, PHD26 worldwide prevalence of DR, particularlySTEVEN HAFFNER, PHD9 NINGLI WANG, MD27 severe vision-threatening stages of the dis-RICHARD F. HAMMAN, PHD10 SHEILA WEST, PHD28 ease, including proliferative DR (PDR) andM. KAMRAN IKRAM, PHD11 LIANG XU, PHD29 diabetic macular edema (DME).TAKAMASA KAYAMA, MD12 MIHO YASUDA, PHD30 Previous individual studies haveBARBARA E.K. KLEIN, PHD13 XINZHI ZHANG, PHD31 shown considerable variability in DRRONALD KLEIN, PHD13 PAUL MITCHELL, PHD26SANNAPANENI KRISHNAIAH, MD14 TIEN Y. WONG, PHD1,2,32 prevalence estimates among individualsKORAPAT MAYURASAKORN, MD15 ON BEHALF OF THE META-ANALYSIS FOR EYE with both diagnosed and undiagnos Continue reading >>

Epidemiology Of Diabetic Retinopathy

Epidemiology Of Diabetic Retinopathy

Acute and chronic complications of diabetes Diabetic retinopathy (DR) is the leading cause of visual loss and blindness in working age populations in the developed world. Although everyone with a diagnosis of diabetes is at risk of developing retinopathy, only a minority progress to sight-threatening complications. These are for the most part preventable. Since the prevalence of diabetes is rising rapidly, particularly in Asian countries, and people are living longer following diagnosis, diabetic retinopathy has emerged as a major public health concern. Despite this, accurate data on its prevalence and outcome worldwide are still lacking. Almost all patients with diabetes show evidence of retinal changes over the course of time, if investigated with sufficiently sensitive techniques, and that a large minority - up to half in some populations - progress to sight-threatening variants of the condition. This proportion has fallen over time, most likely because of improved glucose control, and techniques of ophthalmic management have improved in parallel. Epidemiology has played an essential role in monitoring the impact of diabetic retinopathy at a population level, and the success or failure of public health measures designed to influence the course of this largely preventable condition. Worldwide Prevalence of Diabetic Retinopathy A recent pooled analysis from 35 population-based studies estimated that 93 million people worldwide have diabetic retinopathy, of whom 17 million (~18%) have proliferative DR, 21 million (~23%) have diabetic macular edema (DME), and 28 million (~20%) have sight-threatening DR [1] . Among people with diabetes, this translates to an overall prevalence of 34.6% for any DR, 7.0% for proliferative DR, 6.8% for DME, and 10.2% for sight-threatening D Continue reading >>

[full Text] Prevalence And Risk Factors Of Diabetic Retinopathy Among An Elderly P | Opth

[full Text] Prevalence And Risk Factors Of Diabetic Retinopathy Among An Elderly P | Opth

Editor who approved publication: Dr Scott Fraser Raba Thapa,1 Shankha N Twyana,2 Govinda Paudyal,1 Shankar Khanal,3 Ruth van Nispen,4 Stevie Tan,4 Suman S Thapa,5 GHMB van Rens4 1Vitreo-retina Department, Tilganga Institute of Ophthalmology, Kathmandu, Nepal; 2Department of Eye Bank, Tilganga Institute of Ophthalmology, Kathmandu, Nepal; 3Central Department of Statistics, Tribhuvan University, Kirtipur, Nepal; 4Department of Ophthalmology and the Amsterdam Public Health Research Institute, Vrije University Medical Center, Amsterdam, the Netherlands; 5Glaucoma Department, Tilganga Institute of Ophthalmology, Kathmandu, Nepal Aim: Diabetic retinopathy (DR) is an emerging cause of blindness in developing countries. This study aimed to explore the prevalence and risk factors of DR in an elderly population in Nepal. Subjects and methods: This is a population-based, cross-sectional study. A total of 1860 subjects at the age 60 years and above participated (response rate 88.6%). A detailed history was obtained, presenting and best-corrected visual acuity were measured, and anterior segment and posterior segment examinations were carried out. Blood pressure and random blood sugar were recorded; body mass index was calculated, and abdominal girth was measured. DR was graded by clinical examination using Early Treatment Diabetic Retinopathy Study criteria. Results: Diabetes was found in 168 (9%) subjects (mean age 69.6 years), 31 (18.5%) of whom were newly diagnosed. The prevalence of DR was 23.8% (95% confidence interval [CI]: 17.7%31%) among the persons with diabetes. The prevalence of DR among newly diagnosed subjects with diabetes was 6.5% (95% CI: 0.8%21.4%). The prevalence of vision-threatening DR was 9.5% (95% CI: 5.5%15%) and was higher in males. The prevalence of DR was Continue reading >>

Relative Importance And Contribiton Of Risk Factors For Diabetic Retinopathy And Macular Edema

Relative Importance And Contribiton Of Risk Factors For Diabetic Retinopathy And Macular Edema

Received date January 13, 2014; Accepted date February 12, 2014; Published date February 18, 2014 Citation: Xie J, Fenwick EK, Taouk Y, Nicolaou TE, Wang JJ, et al. (2014) Relative Importance and Contribiton of Risk Factors for Diabetic Retinopathy and Macular Edema. J Diabetes Metab 5:337. doi: 10.4172/2155-6156.1000337 Copyright: 2014 Xie J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Purpose: This study determined the relative importance of risk factors for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) and assessed their independent and joint contributions. Methods: A prospective study of patients with type 2 diabetes was conducted in a tertiary eye hospital in Melbourne, Australia. Patients underwent a comprehensive eye examination and completed standardized administered questionnaires. Blood samples were assessed for glycated haemoglobin (HbA1c); fasting blood glucose; and serum lipids . Dilated fundus photographs were obtained and graded for DR and DME. The relative importance of the risk factors was determined by the independent and common variance explained in DR and DME using Commonality analysis. Results: A total of 497 patients with type 2 diabetes were included in this analysis. The key risk factors accounted for 44.6% and 19.5% of total variances in DR and DME, respectively. The most important risk factor for any DR was duration of diabetes (16.5% of total explained variance), followed by insulin use (13.1%), HbA1c (8.5%), age (3.7%) and gender (2.8%). The most important risk factor for any DME was HbA1c (9.45%); followed by age (5.75%); duration o Continue reading >>

Prevalence Of Referable, Sight-threatening Retinopathy In Type 1 Diabetes And Its Relationship To Diabetes Duration And Systemic Risk Factors

Prevalence Of Referable, Sight-threatening Retinopathy In Type 1 Diabetes And Its Relationship To Diabetes Duration And Systemic Risk Factors

Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors The purpose of the study was to provide contemporary estimates for diabetic retinopathy (DR) prevalence in a well-defined UK cohort of patients with type 1 diabetes (T1DM) and investigate potential risk factors for proliferative diabetic retinopathy (PDR) and diabetic maculopathy. Four hundred and sixty four T1DM patients in North Hampshire had T1DM duration, demographic and systemic risk factor data evaluated retrospectively alongside their DR status in 2010 using logistic regression analysis. Overall prevalence of any retinopathy, PDR, and maculopathy was 71.5%, 6.5%, and 10.8%, respectively. PDR and maculopathy prevalence were 0 and 0.7% for <10 years T1DM duration. PDR prevalence was 4%, 8%, and 16% for 1019.9 years, 2029.9, years and 30 years duration, respectively. Maculopathy prevalence was 15.6%, 18%, and 11% for 1019.9 years, 2029.9 years, and 30 years duration, respectively. In univariate analysis, PDR was associated with T1DM duration (odds ratio (OR) 1.07/year), age (OR 1.03/year), systolic blood pressure (OR 1.03/mmHg), and antihypertensive therapy (OR 10.63), while maculopathy was associated with duration (OR 1.03/year) and statin therapy (OR 2.83). In multivariate analysis, disease duration (OR 1.07/year) and antihypertensive therapy (OR 6.87) remained significantly associated with PDR, and maculopathy with statin therapy (OR 2.27). This study confirms T1DM duration is a strong risk factor for sight-threatening DR. Maculopathy and PDR prevalence within 10 years of T1DM diagnosis is very low. PDR prevalence at 1020 years was 4% and then doubled for every 10-year interval thereafter up to 16% with 30 years duration. Continue reading >>

Proportion Of People With Diabetes With Diabetic Retinopathy Of Any Severity, By Country

Proportion Of People With Diabetes With Diabetic Retinopathy Of Any Severity, By Country

Every year around 75,000 Americans learn that they have atrial fibrillation (AFib)the most common type of arrhythmia, or abnormal heart rhythm. Having AFib puts people at an increased risk for stroke, which can be both deadly and costly. Medicare alone is estimated to pay .7 billion per year to treat newly diagnosed atrial fibrillation patients. Stroke is the 5th leading cause of death in the U.S. and kills more than 129,000 people each year. Someone in the U.S. has a stroke about once every 40 seconds. People do survive stroke--around 795,000 strokes occur each year and there are an estimated 7 million stroke survivors in the U.S.--but they are often left with significant disabilities. Each year around 75,000 Americans are diagnosed with atrial fibrillation (AFib), 900,000 experience a venous thromboembolism event (VTE), and 800,000 have a stroke. The burden for those who survive is enormous and the cost of care a major expense for individuals and the nation. Fortunately research advances are offering significant hope. A number of investigative anticoagulants have the potential to reduce strokes in AFib patients while also reducing the risk of bleeds; clot-dissolving agents are proving to lessen the effects of strokes; and the same drugs in the pipeline for AFib could prevent VTE after major orthopedic surgery. As many as 11.6 million Americans in the U.S. have heart valve disease (HVD), and more than 1 in 10 adults ages 75 and older have HVD. Thankfully, the HVD field has experienced tremendous advances in improving survival, recovery, and quality of life for patients. Aortic stenosis is one of the most common and serious types of heart valve disease. Aortic stenosis can be debilitating, costly, and deadly. Survival rates without treatment for severe symptomatic aort Continue reading >>

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy

Global Prevalence And Major Risk Factors Of Diabetic Retinopathy

Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., ... Wong, T. Y. (2012). Global prevalence and major risk factors of diabetic retinopathy . Diabetes Care , 35(3), 556-564. DOI: 10.2337/dc11-1909 Global prevalence and major risk factors of diabetic retinopathy. / Yau, Joanne W Y; Rogers, Sophie L.; Kawasaki, Rho; Lamoureux, Ecosse L.; Kowalski, Jonathan W.; Bek, Toke; Chen, Shih Jen; Dekker, Jacqueline M.; Fletcher, Astrid; Grauslund, Jakob; Haffner, Steven; Hamman, Richard F.; Ikram, M. Kamran; Kayama, Takamasa; Klein, Barbara E K; Klein, Ronald; Krishnaiah, Sannapaneni; Mayurasakorn, Korapat; O'Hare, Joseph P.; Orchard, Trevor J.; Porta, Massimo; Rema, Mohan; Roy, Monique S.; Sharma, Tarun; Shaw, Jonathan; Taylor, Hugh; Tielsch, James M.; Varma, Rohit; Wang, Jie Jin; Wang, Ningli ; West, Sheila ; Zu, Liang; Yasuda, Miho; Zhang, Xinzhi; Mitchell, Paul; Wong, Tien Y. In: Diabetes Care , Vol. 35, No. 3, 03.2012, p. 556-564. Research output: Contribution to journal Article Yau, JWY, Rogers, SL, Kawasaki, R, Lamoureux, EL, Kowalski, JW, Bek, T, Chen, SJ, Dekker, JM, Fletcher, A, Grauslund, J, Haffner, S, Hamman, RF, Ikram, MK, Kayama, T, Klein, BEK, Klein, R, Krishnaiah, S, Mayurasakorn, K, O'Hare, JP, Orchard, TJ, Porta, M, Rema, M, Roy, MS, Sharma, T, Shaw, J, Taylor, H, Tielsch, JM, Varma, R, Wang, JJ, Wang, N , West, S , Zu, L, Yasuda, M, Zhang, X, Mitchell, P & Wong, TY 2012, ' Global prevalence and major risk factors of diabetic retinopathy ' Diabetes Care , vol 35, no. 3, pp. 556-564. DOI: 10.2337/dc11-1909 Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al. Global prevalence and major risk factors of diabetic retinopathy . Diabetes Care . 2012 Mar;35(3):556-564. Available from, DOI: 10.2337/dc11-1909 Yau, J Continue reading >>

Prevalence Of And Risk Factors For Diabetic Macular Edema In The United States

Prevalence Of And Risk Factors For Diabetic Macular Edema In The United States

Prevalence of Diabetic Macular Edema (DME) Stratified by Race/Ethnicity in the US Population Aged 40 Years or Older in the National Health and Nutrition Examination Survey (NHANES) Error bars represent 95% CIs. Hispanics included both Mexican American and nonMexican American Hispanics. Estimated Prevalence of Diabetic Macular Edema (DME) by Glycosylated Hemoglobin A1c (HbA1c) Levels, Stratified by Diabetes Duration for All Persons With Diabetes Mellitus in the National Health and Nutrition Examination Survey (NHANES) The glycemia-specific prevalence data for all persons by each 0.5% difference were plotted to show the independent relationship of glycemia with prevalence of DME. Margin plots were obtained with a logistic regression model that included HbA1c and the quadratic and cubic terms for HbA1c (P < .01) and adjusted for all other covariates. Probabilities of DME prevalence were estimated using individual HbA1c values for each subject along with the means of all other covariates. Shading represents 95% CIs for the predicted probabilities. Prevalence Estimates Among US Adults With Diabetes Aged 40 Years or Oldera Baseline and Clinical Characteristics of Persons With or Without DME in the US Population Aged 40 Years or Older With Diabetesa Continue reading >>

Prevalence And Risk Factors For Diabetic Retinopathy: The Korea National Health And Nutrition Examination Survey 20082011 | Iovs | Arvo Journals

Prevalence And Risk Factors For Diabetic Retinopathy: The Korea National Health And Nutrition Examination Survey 20082011 | Iovs | Arvo Journals

Clinical and Epidemiologic Research| October 2013 Prevalence and Risk Factors for Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 20082011 Department of Ophthalmology and Visual Science, St. Vincents' Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Department of Ophthalmology and Visual Science, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Correspondence: Won Ki Lee, Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea #505 Ban-po Dong, Seocho-Ku, Seoul, 137-040, Korea; [email protected] . Investigative Ophthalmology & Visual Science October 2013, Vol.54, 6827-6833. doi:10.1167/iovs.13-12654 Prevalence and Risk Factors for Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 20082011 You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account Donghyun Jee, Won Ki Lee, Seungbum Kang; Prevalence and Risk Factors for Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 20082011. Invest. Ophthalmol. Vis. Sci. 2013;54(10):6827-6833. doi: 10.1167/iovs.13-12654. ARVO (1962-2015); The Authors (2016-present) Purpose.: We evaluated the prevalence and risk factors for diabetic retinopathy (DR) in a representative Korean population. Methods.: This cross-sectional study involved 16,109 subjects aged >40 years who had participated in the Korean National Health and Nutrition Survey from 2008 Continue reading >>

Risk Factors For Retinopathy And Dme In Type 2 Diabetesresults From The German/austrian Dpv Database

Risk Factors For Retinopathy And Dme In Type 2 Diabetesresults From The German/austrian Dpv Database

Risk Factors for Retinopathy and DME in Type 2 DiabetesResults from the German/Austrian DPV Database Affiliation 5th Medical Department, University Medical Center, University of Heidelberg, Mannheim, Germany Affiliation Department of Internal Medicine, Knappschafts-Krankenhaus, Bottrop, Germany Affiliation Centre for Diabetes and Nutrition Ludwigshafen, Ludwigshafen, Germany Affiliation Specialized Diabetes Practice, Saaldorf, Germany Affiliation Department of Internal Medicine, St. Josefs Hospital, Heidelberg, Germany Affiliation Institute of Epidemiology and Medical Biometry, University Medical Centre, Ulm, Germany Membership of the DPV consortium is listed in the Acknowledgments. Risk Factors for Retinopathy and DME in Type 2 DiabetesResults from the German/Austrian DPV Database DPV InitiativeGerman BMBF Competence Network Diabetes Mellitus To assess the prevalence and risk factors for early and severe diabetic retinopathy and macular edema in a large cohort of patients with type 2 diabetes Retinopathy grading (any retinopathy, severe retinopathy, diabetic macular edema) and risk factors of 64784 were prospectively recorded between January 2000 and March 2013 and analyzed by KaplanMeier analysis and logistic regression. Retinopathy was present in 20.12% of subjects, maculopathy was found in 0.77%. HbA1c > 8%, microalbuminuria, hypertension, BMI > 35 kg/m2 and male sex were significantly associated with any retinopathy, while HbA1c and micro- and macroalbuminuria were the strongest risk predictors for severe retinopathy. Presence of macroalbuminuria increased the risk for DME by 177%. Retinopathy remains a significant clinical problem in patients with type 2 diabetes. Metabolic control and blood pressure are relevant factors amenable to treatment. Concomitant kidney Continue reading >>

More in diabetes